Target intelligence / Profile preview

Streptococcus pneumoniae type 8 capsular polysaccharide

Molecular classification
Polysaccharide, Capsular Polysaccharide
01

Overview

The Streptococcus pneumoniae type 8 capsular polysaccharide is a serotype-specific, high-molecular-weight carbohydrate polymer that forms the outermost layer of the bacterium. This capsule is a major virulence factor, protecting S. pneumoniae from phagocytosis by host immune cells. The capsule is highly immunogenic and serves as the primary target for current pneumococcal vaccines. Purified type 8 capsular polysaccharide antigen has been used in vaccine formulations such as Pneumovax 23, Prevnar 20, and Capvaxive for active immunization against diseases caused by this serotype. Capsule synthesis genes are located in a dedicated region called the cps locus. Type 8 strains are associated with invasive pneumococcal diseases such as pneumonia and bacteremia. It is used in vaccine development to induce protective immunity against S. pneumoniae infections caused by type 8 strains.

02

Mechanism of action

Induces antibody production against Streptococcus pneumoniae type 8, leading to opsonization and phagocytosis of the bacteria.

03

Biological functions

Immune evasionVirulence factorAntigen presentation (as vaccine component)
04

Disease associations

PneumoniaBacteremiaInvasive pneumococcal disease
05

Safety considerations

Local injection site reactionsPotential for allergic reactionsLimited serotype coverage (vaccine only protects against specific serotypes)
06

Interacting drugs

Pneumovax 23

2 more in the full profile.

Beyond the preview

Go deeper on Streptococcus pneumoniae type 8 capsular polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae type 8 capsular polysaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call